| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $9.86 (Beat by $0.83) |
| EPS GAAP Actual | $9.86 (Beat by $0.83) |
| Revenue Actual | $106.158B |
| Revenue Surprise | Beat by $106158M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Mar 2030 | 60.83 | 15.67 | 58.66528 | 64.13347 | 2 |
| Mar 2029 | 54.98 | 17.34 | 52.52 | 60.55776 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 9.63 | 9.63 | 106.158B | 10.23% | 106158M |
| FQ3 2025 (Sep 2025) | 8.95 | 8.95 | 103.15B | 9.21% | 103150M |
| FQ2 2025 (Jun 2025) | 6.28 | 6.28 | 97.827B | 18.96% | 97827M |
| FQ1 2025 (Mar 2025) | 10.06 | 10.06 | 90.823B | 15.93% | 90823M |
| FQ4 2024 (Dec 2024) | 6.98 | 6.98 | 95.294B | 15.11% | 95294M |
| FQ3 2024 (Sep 2024) | 7.96 | 7.96 | 93.651B | 17.55% | 93651M |
| FQ2 2024 (Jun 2024) | 7.05 | 7.05 | 79.283B | 6.05% | 79283M |
| FQ1 2024 (Mar 2024) | 6.05 | 6.05 | 76.355B | 9.75% | 76355M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2030 (Mar 2030) | 17.98 | -- | 17.593 | 18.65062 | 4 |
| FQ4 2029 (Dec 2029) | 16.6 | -- | 16.36203 | 16.92093 | 3 |
| FQ3 2029 (Sep 2029) | 14.86 | -- | 14.64698 | 15.14729 | 6 |
| FQ2 2029 (Jun 2029) | 14.69 | -- | 14.47941 | 14.974 | 3 |
| FQ1 2029 (Mar 2029) | 15.83 | -- | 15.60307 | 16.13604 | 3 |
| FQ4 2028 (Dec 2028) | 14.63 | -- | 14.42027 | 14.91284 | 4 |
| FQ3 2028 (Sep 2028) | 13.06 | -- | 12.87278 | 13.31249 | 6 |
| FQ2 2028 (Jun 2028) | 12.92 | -- | 12.73479 | 13.16978 | 4 |
| FQ1 2028 (Mar 2028) | 13.26316 | -- | 12.98539 | 13.58944 | 4 |
| FQ4 2027 (Dec 2027) | 11.93005 | -- | 11.6802 | 12.22354 | 7 |
| FQ3 2027 (Sep 2027) | 11.3 | -- | 11.3 | 11.3 | 4 |
| FQ2 2027 (Jun 2027) | 10.51 | -- | 10.51 | 10.51 | 4 |
| FQ1 2027 (Mar 2027) | 11.14905 | -- | 11.14905 | 11.14905 | 4 |
| FQ4 2026 (Oct 2026) | 9.78003 | 1.53 | 9.3948 | 10.40765 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2030 (Mar 2030) | 135.3B | -- | 133.06B | 139.18B | 4 |
| FQ4 2029 (Dec 2029) | 141.64B | -- | 140.08B | 143.75B | 4 |
| FQ3 2029 (Sep 2029) | 138.97B | -- | 137.43B | 141.03B | 7 |
| FQ2 2029 (Jun 2029) | 133.19B | -- | 131.72B | 135.17B | 4 |
| FQ1 2029 (Mar 2029) | 126.18B | -- | 124.79B | 128.06B | 4 |
| FQ4 2028 (Dec 2028) | 132.12B | -- | 130.66B | 134.09B | 3 |
| FQ3 2028 (Sep 2028) | 129.63B | -- | 128.2B | 131.55B | 5 |
| FQ2 2028 (Jun 2028) | 124.21B | -- | 122.84B | 126.06B | 3 |
| FQ1 2028 (Mar 2028) | 116.38B | -- | 114.51B | 118.58B | 3 |
| FQ4 2027 (Dec 2027) | 123.26B | -- | 121.27B | 125.59B | 6 |
| FQ3 2027 (Sep 2027) | 120.93B | -- | 120.93B | 120.93B | 5 |
| FQ2 2027 (Jun 2027) | 113.84B | -- | 113.84B | 113.84B | 4 |
| FQ1 2027 (Mar 2027) | 103.25B | -- | 103.25B | 103.25B | 7 |
| FQ4 2026 (Oct 2026) | 103.16B | -2.91 | 100.03B | 108.25B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 9.63 | 9.63 | 100% | |
| FQ3 2025 (Sep 2025) | 8.95 | 8.95 | 100% | |
| FQ2 2025 (Jun 2025) | 6.28 | 6.28 | 100% | |
| FQ1 2025 (Mar 2025) | 10.06 | 10.06 | 100% | |
| FQ4 2024 (Dec 2024) | 6.98 | 6.98 | 100% | |
| FQ3 2024 (Sep 2024) | 7.96 | 7.96 | 100% | |
| FQ2 2024 (Jun 2024) | 7.05 | 7.05 | 100% | |
| FQ1 2024 (Mar 2024) | 6.05 | 6.05 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $106.16B | $106158M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $103.15B | $103150M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $97.83B | $97827M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $90.82B | $90823M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $95.29B | $95294M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $93.65B | $93651M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $79.28B | $79283M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $76.36B | $76355M | 100% |